EXHIBIT 99.1 Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results Company confirms Current Procedural Terminology (“CPT®”) Category 1 application for TULSA TORONTO, March 07, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full y ...